Although CgA is a widely studied histopathological and serological marker for neuroendocrine tumors, this is the first evidence that circulating full-length CgA, released in the blood by the neuroendocrine system, has a functional role in non-neuroendocrine tumors. This evidence concerns the gene CGA and neuroendocrine neoplasm.